Ranibizumab may help drivers with macular degeneration

NEW YORK (Reuters Health) – In patients with age-related macular degeneration (AMD), ranibizumab
(Lucentis, Genentech) seems to improve self-reported driving ability more than sham treatment or photodynamic
therapy, according to researchers.
Source: Modern Medicine: Optometry